Related Experiment Video
Updated: Jan 29, 2026

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
Published on: August 6, 2019
Total Methionine Restriction Treatment of Cancer
Robert M Hoffman1,2, Demetrius M Kokkinakis3, Eugene P Frenkel4
1AntiCancer, Inc., San Diego, CA, USA. all@anticancer.com.
Total methionine restriction (MR), achieved with a special diet and enzyme therapy, significantly enhances chemotherapy for brain tumors in mice. This approach slows tumor growth and potentiates standard treatments like BCNU and temozolomide.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Background:
- Methionine (MET) is an essential amino acid crucial for cell proliferation.
- Cancer cells often exhibit higher dependence on methionine metabolism.
- Targeting methionine metabolism presents a potential therapeutic strategy for brain tumors.
Purpose of the Study:
- To investigate the efficacy of total methionine restriction (MR) in potentiating chemotherapy for human brain tumor xenografts in mice.
- To evaluate the combined effects of a methionine-free diet, recombinant L-methionine-α-deamino-γ-lyase (rMETase), and standard chemotherapeutic agents.
Main Methods:
- Human brain tumor xenografts (Daoy, SWB77, D-54) were established in nude mice.
- Methionine restriction was induced using a combination of an MR diet and rMETase, achieving plasma methionine levels below 5 μm.
- Homocysteine was administered to rescue normal cells.
- Chemotherapeutic agents, N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU) and temozolomide (TMZ), were administered post-MR regimen.
Main Results:
- Total MR effectively arrested the growth of Daoy, SWB77, and D-54 xenografts.
- MR alone inhibited tumor growth but did not prevent regrowth after treatment cessation.
- A single dose of BCNU following MR resulted in >80-day growth delay for Daoy and D-54, and a 20-day delay for SWB77.
- MR treatment regimens enhanced the efficacy of TMZ against the SWB77 xenograft.
Conclusions:
- Total methionine restriction is a potent strategy to enhance the efficacy of standard chemotherapy for brain tumors.
- Combining MR with agents like BCNU and TMZ shows significant promise in controlling brain tumor xenograft growth in preclinical models.
- Targeting methionine metabolism offers a viable approach to overcome therapeutic resistance in brain cancers.
Related Concept Videos
Treatment Resistant Cancers
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Total Voids in Concrete
Total Internal Reflection Fluorescence Microscopy
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...

